Cunha et al. reported a 2-phase pilot study of CBD versus placebo in normal volunteers and patients with refractory secondarily generalized epilepsy (14). In the first phase, 8 normal volunteers received CBD or placebo in a doubled-blind fashion, at a dose of 3 mg/kg for 30 days. The second phase was also double-blinded in 15 patients with epilepsy receiving 200 to 300 mg daily of CBD or placebo for 135 days. Patients continued baseline AED. All subjects tolerated CBD well, with no serious adverse events. Four of the epilepsy patients receiving CBD were “almost free of convulsive crisis” for the duration of the study. Three other patients receiving CBD had a partial reduction in seizures, and 1 subject had no response. Of the 7 patients receiving placebo, seizure frequency was unchanged in 6, and 1 had clear improvement in seizure control.
Transparency: Moon Mother sends each batch of product to a third-party lab to be tested for potency as well as other contaminants. You can find all of these lab reports on the company’s website. They also added more information about their company processes to the website, so it’s easier to find important information about extraction and manufacturing.
Rather, what most of these oils appear to be are extracts of the hemp seed. As we mentioned earlier, CBD oil can be made from either hemp or marijuana cannabis plants. No matter which plant they come from, however, they must be made using the flowers, leaves, stem and stalks of the plant, as these are the parts where the CBD compound is actually located.
×